Status:
COMPLETED
Non-interventional Observational Study on WHO-5 Questionnaire Application in Parkinson's Disease
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Parkinson Disease
Eligibility:
All Genders
30+ years
Brief Summary
To assess the predictive value of sequential administration of WHO-5 and MDI (Major Depression Inventory) for the clinical management of Parkinson Disease (PD) patients by * determination of the prev...
Eligibility Criteria
Inclusion
- PD patients attending one of the participating neurologist practices during 2 fixed weeks in November 2008
- Idiopathic PD with or without fluctuations
- Male or female PD patients aged at least 30
- Ability to reliably complete self-rating scales (WHO-5, MDI) ), according to the physician's judgement.
- Written informed consent by the patient for study participation.
Exclusion
- PD Patients who only attend the practice to get a prescription and are not seen by the doctor on that day
- Patients who are not able to understand the questionnaires (e.g. due to mental impairment or language problems).
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
1588 Patients enrolled
Trial Details
Trial ID
NCT00752388
Start Date
November 1 2008
Last Update
November 19 2013
Active Locations (278)
Enter a location and click search to find clinical trials sorted by distance.
1
Boehringer Ingelheim Investigational Site 1
Achim, Germany
2
Boehringer Ingelheim Investigational Site 2
Achim, Germany
3
Boehringer Ingelheim Investigational Site
Altenburg, Germany
4
Boehringer Ingelheim Investigational Site
Altenholz, Germany